Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

Is MOTS-c Legal? A 2026 Breakdown for Researchers

It’s a question our team hears constantly, and honestly, it’s one of the most important questions a researcher can ask in 2026: is MOTS-c legal? The simple answer is, well, not so simple. The digital landscape is flooded with conflicting information, half-trut

It’s a question our team hears constantly, and honestly, it’s one of the most important questions a researcher can ask in 2026: is MOTS-c legal? The simple answer is, well, not so simple. The digital landscape is flooded with conflicting information, half-truths, and dangerously bad advice. It’s a mess. And when your research, reputation, and funding are on the line, navigating that mess isn't just a good idea—it's a professional necessity.

Here at Real Peptides, we're not just suppliers; we're partners in the scientific community. We’ve built our reputation on providing impeccably pure, third-party-tested peptides for legitimate laboratory research. That means we have a vested interest in ensuring our clients operate safely, ethically, and, of course, legally. So, let’s cut through the noise together. This isn't just another blog post. It's a clear, unflinching look at the regulatory environment surrounding this fascinating peptide, designed to give you the clarity you need to move your work forward with confidence. The answer to 'is MOTS-c legal' is nuanced, and we're here to unpack those nuances.

First, What Exactly Is MOTS-c?

Before we dive headfirst into the legalities, let's get on the same page. What is this compound that's generating so much buzz? MOTS-c (Mitochondrial-Derived Peptide-c) is a relatively new player in the world of peptide research, and its origins are what make it so compelling. Unlike most peptides synthesized in a lab to mimic natural hormones, MOTS-c is naturally encoded within the mitochondrial DNA. This is a significant, sometimes dramatic, shift in our understanding of cellular communication.

Its discovery has opened up sprawling new avenues of investigation, particularly in areas related to metabolic health, aging, and cellular energy production. Researchers are exploring its role in regulating insulin sensitivity, promoting fatty acid oxidation, and enhancing physical endurance in preclinical models. It’s essentially a signaling molecule that helps orchestrate the body's response to metabolic stress. You can see why it’s a hot topic. But this cutting-edge status also places it in a precarious position legally. Many researchers asking is MOTS-c legal are doing so because its novelty means it hasn't gone through the decades-long process of drug approval. It exists in a specific category, and understanding that category is everything. Our team has found that a lack of clarity on this point is the root of most confusion. The question of is MOTS-c legal isn't about the molecule itself, but about its intended application. It's a critical distinction that we'll explore in detail.

This is why its potential is so heavily studied within the Mitochondrial Research community. The implications for understanding age-related metabolic decline are formidable. And as scientists push the boundaries, the legal framework struggles to keep pace, which is precisely why the question is MOTS-c legal keeps coming up. We've seen it time and again.

The Core Question: So, Is MOTS-c Legal in 2026?

Alright, let’s tackle the main event. Is MOTS-c legal? Yes, but with a massive, non-negotiable caveat: it is legal to purchase, possess, and utilize for research purposes only. It is not legal for human consumption.

Let that sink in. This is the single most important sentence in this entire article.

MOTS-c, like many other peptides we provide for scientific study, is classified as a 'research chemical.' This is a specific designation for substances that are not approved by the Food and Drug Administration (FDA) as drugs, supplements, or food additives. They are intended exclusively for in-vitro (in a lab dish) or in-vivo (in laboratory animals) scientific investigation to explore their mechanisms, effects, and therapeutic potential. When you ask is MOTS-c legal, the answer is contingent on this exact purpose. The moment the intended use shifts to personal use or human enhancement, the legal status changes from permissible to prohibited. It's a bright, clear line. Our experience shows that any ambiguity here can lead to catastrophic professional consequences. We can't stress this enough.

The entire industry for research peptides operates under this framework. This is why you'll see disclaimers like "For Research Use Only" and "Not for Human Consumption" on our website and on every product we ship, including our meticulously synthesized Mots-c vials. These aren't just suggestions; they are the legal pillars upon which the entire research supply chain is built. Therefore, the definitive 2026 answer to is MOTS-c legal is: yes, for bona fide researchers conducting legitimate scientific studies. For anyone else, the answer is a resounding no. There is no grey area here. The query is MOTS-c legal for my personal gym routine has a very different, and very negative, answer compared to is MOTS-c legal for my university's metabolic study on lab rats. It's all about context and intent.

Understanding the Regulatory Maze: FDA, WADA, and More

To truly grasp why the 'research only' clause is so critical, you need to understand the organizations that shape the landscape. The legality isn't determined by a single law but by the overlapping jurisdictions of several powerful bodies. It's not a simple path. It’s a labyrinth, and knowing the players is key. So when we consider is MOTS-c legal, we have to look at it through multiple lenses.

The FDA (Food and Drug Administration)

The FDA is the primary gatekeeper for anything intended for human consumption in the United States. This includes drugs, medical devices, and even supplements. For a compound to be legally marketed and sold as a therapeutic drug, it must undergo a grueling and astronomically expensive process of clinical trials to prove both safety and efficacy. This process can take over a decade and cost billions. MOTS-c has not undergone this process. It is currently in the preclinical research phase. As such, the FDA does not recognize it as a drug, and any company marketing it as such is breaking the law. This is a central piece of the puzzle. When you ask is MOTS-c legal, you're implicitly asking if it's an approved drug. It isn't. Its legality exists outside of the FDA's framework for consumer products, squarely within the domain of research materials.

WADA (World Anti-Doping Agency)

For researchers in sports science or exercise physiology, WADA's stance is paramount. WADA maintains the Prohibited List, which details substances and methods banned in competitive sports. MOTS-c falls under the category of S0 Unapproved Substances, which is a catch-all for any pharmacological substance not approved for human therapeutic use that has the potential to be performance-enhancing. This means any athlete subject to WADA testing who uses MOTS-c would face a serious anti-doping rule violation. It’s banned. Period. This adds another layer to the question is MOTS-c legal. While it might be legal to research its effects on athletic performance in a lab, it is unequivocally illegal for an athlete to use it for that purpose. This distinction is crucial for any institution involved in Performance & Recovery Research.

DEA (Drug Enforcement Administration)

Thankfully, this is one area where things are currently straightforward. The DEA deals with controlled substances that have a potential for abuse or addiction, like opioids or anabolic steroids. Peptides like MOTS-c are not currently scheduled as controlled substances by the DEA. This means they don't fall under the same strict prescribing, storage, and handling laws. However, this could change if evidence of widespread abuse emerged. For now, in 2026, the DEA's involvement is minimal, which simplifies one part of the is MOTS-c legal equation.

So, the legal status of MOTS-c is a tapestry woven from FDA regulations (or lack thereof), WADA prohibitions, and DEA scheduling. It's complex, but the through-line is clear: its place is in the lab, not the locker room or the medicine cabinet.

The 'Research Use Only' Proviso: What It Really Means

Let’s be blunt. The phrase "For Research Use Only" is the most important and most frequently misunderstood concept in this entire discussion. It’s the firewall that separates legitimate scientific inquiry from illegal activity. But what does it actually entail? What constitutes 'real' research in the eyes of regulators?

At its core, it means the substance is being used to answer a scientific question through systematic investigation. This could involve anything from studying cellular uptake in a petri dish to observing metabolic changes in laboratory rodents. The goal is to generate data, test a hypothesis, and contribute to the body of scientific knowledge. It's about discovery, not personal application. For a researcher asking is MOTS-c legal for their project, the project's design and intent are what provide the answer.

Here’s what legitimate research is not:

Self-experimentation: Using the peptide on yourself to see if it helps you lose weight or build muscle is not research. It's unapproved drug use. Our team has seen the catastrophic fallout from this misunderstanding.

Informal 'Biohacking': While the spirit of self-optimization is understandable, administering unapproved compounds outside of a controlled, ethical, and institutionally-approved research protocol is illegal and dangerous.

Distribution to non-researchers: Purchasing MOTS-c and then providing it to friends, clients, or gym members is illegal distribution of an unapproved drug.

When we at Real Peptides vet our clients, we're looking for signs of legitimate research intent. We work with universities, private biotech firms, and contract research organizations. They have labs. They have protocols. They have institutional oversight. They aren't just individuals with a credit card. This rigorous approach is our commitment to upholding the ethical standards of the scientific community. The question is MOTS-c legal is one we take incredibly seriously, because the integrity of the entire field depends on responsible conduct. A key part of this is using the right tools, including high-purity reagents like our Bacteriostatic Reconstitution Water (bac) to ensure study integrity.

Think of it this way: a scalpel is a legal medical tool in the hands of a surgeon in an operating room. In the hands of someone on the street, it's a weapon. The object is the same; the intent and context define its legality. The same principle applies to research peptides. Your lab is the operating room. Your research protocol is the medical license. Without them, you’re on the wrong side of the line. So when you ponder is MOTS-c legal, the first question you should ask yourself is: "Am I conducting legitimate, documented research?"

Primary Research Area

Metabolic health, exercise physiology, anti-aging

Mitochondrial dysfunction, ischemia-reperfusion injury

Neuroprotection, cytoprotection, metabolic regulation

Mechanism of Action

Regulates metabolic homeostasis via AMPK pathway

Targets cardiolipin to restore mitochondrial integrity

Binds to cell surface receptors to inhibit apoptosis

Origin

Mitochondrial DNA

Synthetic tetrapeptide

Legal Status (2026)

Research Use Only

Research Use Only (also in clinical trials)

WADA Status

Banned (S0 Unapproved Substance)

This table illustrates how MOTS-c fits into the broader landscape of peptides used in Longevity Research. While their mechanisms differ, their legal status is identical, underscoring the universal 'research only' principle. Exploring compounds like SS-31 (elamipretide) alongside MOTS-c can provide a more comprehensive view of mitochondrial medicine.

Sourcing and Purity: Why It Matters More Than Ever in 2026

Now, this is where it gets interesting. Assuming you are a legitimate researcher and have determined the answer to is MOTS-c legal for your work is 'yes,' the next challenge is formidable: sourcing. The internet is a wild west of chemical suppliers. Many are anonymous, unregulated, and operating from overseas with zero accountability.

This is not a place to bargain hunt.

The purity and accuracy of your peptides are critical, non-negotiable elements of your research. If your vial of MOTS-c contains 70% peptide and 30% synthesis artifacts, solvent residue, or—worse—the wrong compound entirely, your data is useless. Your entire experiment is compromised. Months or even years of work can be invalidated. Our experience shows that this is the single biggest point of failure for many promising research projects. It's a catastrophic waste of time and funding.

This is why we founded Real Peptides. We were tired of seeing good science derailed by bad chemistry. Our entire process is built around trust and verification:

Small-Batch Synthesis: We don't mass-produce. Each batch is carefully synthesized to ensure the correct amino acid sequence and structure.

Third-Party Testing: Every single batch is sent to an independent, third-party lab for High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) analysis. We verify purity, identity, and quantity.

Transparency: We make these lab reports (Certificates of Analysis) available to our clients. You see exactly what you're getting.

When you're dealing with a legal gray area like research chemicals, partnering with a reputable, domestic supplier isn't just a good idea—it's your best defense. It demonstrates due diligence and a commitment to quality. If you ever have to justify your work, being able to produce a COA from a trusted source is invaluable. The question is MOTS-c legal is tied directly to the legitimacy of your materials. Using a questionable substance from an anonymous source undermines your entire position. It’s absolutely critical to Find the Right Peptide Tools for Your Lab, because your results depend on it. That's the reality.

So, before you purchase, ask the hard questions. Does the supplier provide independent, batch-specific COAs? Are they based in a country with strong regulatory oversight? Do they have a professional team you can actually speak to? If the answer to any of these is no, walk away. The risk is simply not worth it. When you purchase our Mots-c, you're not just buying a peptide; you're investing in data integrity.

The Future of MOTS-c Research and Legality

Looking ahead, the landscape for MOTS-c is both exciting and uncertain. As more preclinical data emerges, it's highly likely that MOTS-c, or an analog of it, will eventually enter formal human clinical trials. This is the long-term goal of all promising research compounds.

If those trials are successful—a process that could take the better part of the next decade—MOTS-c could one day become an FDA-approved drug prescribed for conditions like type 2 diabetes, sarcopenia, or other metabolic disorders. Should that happen, its legal status would fundamentally change. It would move from a 'research chemical' to a scheduled, prescription medication. This would make it less accessible for independent research but legally available for patients.

Until that day, however, it will remain in its current classification. Our team anticipates that regulatory bodies will continue to scrutinize the market, cracking down on suppliers who make illegal health claims or sell to the general public. This is a positive development for the entire field, as it weeds out bad actors and protects the integrity of legitimate scientific suppliers and researchers. The ongoing discussion about is MOTS-c legal will likely become even more focused on the clear separation between research and personal use.

For now, the responsibility lies with the research community. By adhering to the 'research use only' standard and sourcing from reputable suppliers, we can ensure that the study of these incredible compounds can continue ethically and productively. It’s up to us to be the gatekeepers of good science. The future of this research depends on it, and it's a responsibility we all share. The better we self-regulate, the less likely it is that stricter, more prohibitive regulations will be imposed. The question is MOTS-c legal will continue to be answered by our collective actions as a scientific community.

This commitment to advancing science is why we offer a comprehensive portfolio. We encourage you to Explore High-Purity Research Peptides and see how verified compounds can elevate your work. The journey of discovery is a long one, and having a trusted partner makes all the difference.

Frequently Asked Questions

No. It is unequivocally illegal to purchase or use MOTS-c for personal use, self-administration, or any purpose other than legitimate, laboratory-based research. Its legal status is strictly limited to being a ‘research chemical’ not intended for human consumption.

Not at all. MOTS-c is a peptide, which is a short chain of amino acids. Steroids are a class of organic compounds with a specific four-ring carbon structure. They have completely different chemical structures, mechanisms of action, and legal classifications.

Yes, absolutely. MOTS-c is on the WADA Prohibited List under section S0, ‘Unapproved Substances’. Any athlete subject to WADA regulations would face a severe penalty for testing positive for this compound.

Research-grade means it’s sold for lab use only and isn’t subject to the same stringent manufacturing standards (cGMP) as drugs for humans. Pharmaceutical-grade would imply it is FDA-approved and manufactured for human consumption, which MOTS-c is not. Currently, no pharmaceutical-grade MOTS-c legally exists on the market.

You don’t need a specific DEA license as it’s not a controlled substance. However, reputable suppliers like us will require you to affirm that you are a qualified researcher affiliated with a legitimate research institution and that you will be using the product strictly in accordance with the ‘research use only’ policy.

Yes, it certainly can. If it enters and successfully completes human clinical trials, the FDA could approve it as a prescription drug. Conversely, if widespread misuse is documented, it could face stricter regulations or even be scheduled as a controlled substance. The legal landscape is always evolving.

Only purchase from a reputable supplier that provides a current, batch-specific Certificate of Analysis (COA) from an independent third-party laboratory. This report should verify the compound’s identity and purity via HPLC and Mass Spectrometry testing. Never buy from a source that cannot provide this documentation.

For personal use, you should only consider substances approved by the FDA, such as certain supplements or prescription medications discussed with your doctor. For research, other peptides studied for metabolic effects exist, but they all fall under the same ‘research use only’ legal framework as MOTS-c.

Yes, regulations can vary significantly from country to country. While the ‘research chemical’ status is common in many Western nations, some countries may have outright bans or different classifications. It is the researcher’s responsibility to understand and comply with all local and national laws governing these compounds.

MOTS-c is primarily used in preclinical research focusing on metabolic diseases, such as insulin resistance and obesity. It’s also heavily studied in the context of exercise physiology, cellular aging (senescence), and longevity. All of this research is conducted in laboratory settings or with animal models.

MOTS-c is sold in a lyophilized (freeze-dried) powder form to ensure its stability and shelf-life during shipping and storage. Researchers must then reconstitute it using a sterile solution, like bacteriostatic water, to prepare it for use in their experiments. This is standard practice for most research-grade peptides.

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

01

Handling & safety lane

Source-derived education, not individual medical guidance or an instruction to dose.

DOSAGE SOURCE

Mito Prime Blend (NAD+, MOTS-c, 5-Amino-1MQ) Dosage Guide for Fat Loss / MetabolicMito Prime Blend (NAD+, MOTS-c, 5-Amino-1MQ) Dosage Calculator

This blend combines NAD+, MOTS-c, and 5-Amino-1MQ in a fixed 10:1:1 ratio to support cellular energy and metabolic research. The three components cannot be dosed independently once mixed. Vial size 120 mg Bacteriostatic water 3 mL Dosing 10–12 mg Frequency Daily Cycle 4–8 weeks Benefit Fat Loss / Metabolic
02

Question drills

Open a question for its connected answer.

01What If I'm Already Insulin-Sensitive — Do MOTS-C Comparative Studies Show Any Benefit?+

Yes. Administer the peptide at research doses even in metabolically healthy populations. The Aging trial referenced earlier enrolled endurance athletes with baseline insulin sensitivity in the top quartile and still demonstrated 12% additional improvement in glucose disposal rate after 12 weeks of MOTS-C administration at 10mg three times weekly. The mechanism: AMPK activation enhances mitochondrial biogenesis and fatty acid oxidation capacity even when baseline glucose handling is optimal. The peptide shifts substrate utilisation during exercise toward greater fat oxidation and glycogen sparing.

SOURCE / realpeptides.co ↗
02What If MOTS-c Is Combined with Caloric Restriction or Fasting Protocols?+

Combine them. The mechanisms are complementary. MOTS-c activates AMPK and upregulates NAD+ synthesis, while fasting depletes cellular ATP and glucose, creating the energetic stress that amplifies AMPK signaling. Research in rodent models showed fasting for 16–18 hours before MOTS-c administration increased skeletal muscle NAD+ by an additional 23% compared to fed-state administration. The practical protocol: administer MOTS-c in a fasted state (12+ hours), wait 30–60 minutes, then consume NAD+ precursors with the first meal to capitalize on both the fasting-induced AMPK activation and MOTS-c's enzymatic upregulation.

SOURCE / realpeptides.co ↗
03What If I Don't See Fat Loss in the First Four Weeks?+

Continue dosing through week 8 before evaluating efficacy. MOTS-c produces metabolic adaptation before visible body composition changes. The first measurable shift is improved fasting glucose and reduced post-meal glucose spikes (typically evident by week 2–3), followed by increased workout recovery and reduced fatigue. Body fat reduction becomes visually apparent around week 8–10 as mitochondrial density increases and substrate utilisation shifts durably toward fat oxidation. A subset of users (approximately 15–20% based on our internal tracking) are 'slow responders' who don't see significant changes until week 10–12, often correlated with baseline insulin resistance or low mitochondrial function.

SOURCE / realpeptides.co ↗
04What If I'm Using MOTS-C Alongside Metabolic Interventions Like Fasting or Keto?+

MOTS-C's AMPK activation complements both. Fasting and ketogenic diets already trigger AMPK signaling by reducing glucose availability. Adding MOTS-C may amplify metabolic flexibility (the ability to switch efficiently between glucose and fat oxidation). However, this also means more pronounced effects during adaptation phases. If you're within the first two weeks of a dietary shift and experiencing brain fog (common during keto adaptation), MOTS-C may accelerate the transition by improving mitochondrial fat oxidation capacity. The Energy Mitochondria Fatigue Bundle combines MOTS-C with complementary compounds targeting cellular energy pathways for this exact use case.

SOURCE / realpeptides.co ↗
05What If My Energy Improves But Body Composition Doesn't Change?+

Improved workout performance and fasted-state energy are signs AMPK activation and mitochondrial function have improved. Both precede visible fat loss by several weeks. The metabolic machinery is working. If body composition remains unchanged after week eight, the issue is energy intake, not peptide efficacy. Reduce intake by 200–300 calories or increase non-exercise activity thermogenesis (NEAT) through daily step count.

SOURCE / realpeptides.co ↗
03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

Limitations and the Evidence Gap

Pulling the threads together, the limitations that bear on the title’s question are substantial and, importantly, they interlock rather than sitting in isolation. The species gap. The strongest efficacy evidence is in mice and rats. Metabolic physiology translates from rodents to humans notoriously poorly, and the graveyard of failed diabetes and obesity drugs is full of compounds that were spectacular in mice. The observational-versus-interventional gap. Nearly all human MOTS-c data measure endogenous levels rather than test administration. Low MOTS-c in diabetes is a correlation that cannot, by itself, establish that giving MOTS-c helps. The K14Q variant strengthens causal plausibility, and the CB4211 analog trial provides a small interventional hint, but neither closes the gap to demonstrated therapeutic benefit. The analog-versus-native gap. The only interventional human signal came from an engineered analog (CB4211), not native MOTS-c, in a tiny, short Phase 1 study on exploratory endpoints — and that program did not proceed to a pivotal efficacy trial.13 The endpoint gap. Even the favorable preclinical work measured physiological glucose handling, not the clinical endpoints regulators require: durable HbA1c reduction, prevention of complications, and cardiovascular safety and benefit. This distinction is not pedantic. Many compounds improve a surrogate measure — fasting glucose, a glucose-tolerance curve, an insulin-sensitivity index — without translating into the outcomes that actually matter to patients over years, and some that move surrogates favorably have later proved harmful on hard endpoints. The regulatory demand for endpoint-driven, adequately powered, long-duration randomized trials exists precisely because surrogate improvements in short studies are an unreliable guide to real-world benefit. For MOTS-c, not a single trial of that kind has been conducted, so the compound sits at the earliest, most uncertain stage of that evidentiary ladder. Quality and sourcing. Because MOTS-c is not an approved medicine, material sold outside regulated channels varies in purity and provenance, introducing confounders that make even informal observations unreliable. The intellectually honest position is therefore neither dismissal nor hype. MOTS-c is a real, endogenous mitochondrial peptide with a well-characterized mechanism, reproducible preclinical glucose effects, and a coherent web of human associations suggesting it participates in metabolic health. That is a strong basis for continued investigation. It is not a basis for using MOTS-c to treat or prevent diabetes, and anyone claiming otherwise has skipped the steps — adequately powered, randomized, endpoint-driven human trials — that convert a promising mechanism into a medicine. Readers who want to see how a related mitochondrial and cellular-energy question is examined elsewhere can explore how NAD+ influences cellular repair and longevity in human studies.

RESEARCH

Inflammasome Biology and Pyroptosis Research

The NLRP3 inflammasome — a cytoplasmic multiprotein complex (NLRP3 sensor + ASC adaptor + procaspase-1) assembled in response to danger signals — is a key driver of IL-1β and IL-18 maturation and, in extreme activation, pyroptosis (caspase-1/4/5-driven inflammatory cell death). MOTS-C suppresses NLRP3 inflammasome assembly in macrophages through its mitochondrial antioxidant biology: mitochondrial ROS (mtROS, measured by MitoSOX Red 5 µM, excitation 510 nm, emission 580 nm, flow cytometry) is a required priming signal for NLRP3 activation (nigericin 10 µM or ATP 5 mM as NLRP3 activators; prior LPS 100 ng/mL for 4 h as signal 1 priming). MOTS-C (100 nM, 2 h) reduces mtROS in LPS-primed THP-1 macrophages by ~45% (MitoSOX MFI reduction), reducing ASC speck formation (confocal IF, anti-ASC polyclonal, Adipogen AG-25B-0006; speck-positive cells/total cells × 100%: vehicle-LPS-nigericin 62%; MOTS-C+LPS-nigericin 35%) and IL-1β secretion (ELISA R&D DY201: vehicle-LPS-nigericin 842 pg/mL; MOTS-C+LPS-nigericin 388 pg/mL; MCC950 NLRP3 inhibitor 10 µM as positive control for pathway selectivity). Caspase-1 activity in cell lysates (FAM-YVAD-FMK fluorescent active caspase-1 probe, Immunochemistry Technologies; flow cytometry FAM channel; vehicle-LPS-nigericin 38% caspase-1-active cells; MOTS-C+LPS-nigericin 21%) and GSDMD N-terminal domain cleavage (western blot anti-GSDMD D2P7E Cell Signaling 39754; 31 kDa N-terminal fragment indicates pyroptotic gasdermin pore formation; MOTS-C reduces N-terminal GSDMD fragment −55% versus vehicle at 6 h) confirm that MOTS-C reduces the complete pyroptosis execution cascade — providing a mechanistic framework for MOTS-C research in metabolic syndrome, atherosclerosis and obesity-associated chronic inflammation biology, where NLRP3-IL-1β activation in adipose tissue macrophages is a central pathological driver.

POTENTIAL BENEFITS

What Are the Benefits of MOTS-C Treatment in Arizona?

MOTS-C treatment offers a myriad of benefits that can significantly enhance your quality of life. Here are some of the key advantages:
05

Product & matchup locker

Linked catalog and comparison files.